CA3021061C - Derivatives of amphotericin b - Google Patents

Derivatives of amphotericin b Download PDF

Info

Publication number
CA3021061C
CA3021061C CA3021061A CA3021061A CA3021061C CA 3021061 C CA3021061 C CA 3021061C CA 3021061 A CA3021061 A CA 3021061A CA 3021061 A CA3021061 A CA 3021061A CA 3021061 C CA3021061 C CA 3021061C
Authority
CA
Canada
Prior art keywords
compound
alkyl
cycloalkyl
substituted
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3021061A
Other languages
English (en)
French (fr)
Other versions
CA3021061A1 (en
Inventor
Martin D. Burke
Arun P. Thottumkara
Kevin T. Mellem
Zachary K. Sweeney
Elena S. Koltun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elion Therapeutics Inc
Original Assignee
Sfunga Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sfunga Therapeutics Inc filed Critical Sfunga Therapeutics Inc
Priority to CA3213127A priority Critical patent/CA3213127A1/en
Publication of CA3021061A1 publication Critical patent/CA3021061A1/en
Application granted granted Critical
Publication of CA3021061C publication Critical patent/CA3021061C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CA3021061A 2015-04-15 2016-04-15 Derivatives of amphotericin b Active CA3021061C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA3213127A CA3213127A1 (en) 2015-04-15 2016-04-15 Derivatives of amphotericin b

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562147949P 2015-04-15 2015-04-15
US62/147,949 2015-04-15
PCT/US2016/027703 WO2016168568A1 (en) 2015-04-15 2016-04-15 Derivatives of amphotericin b

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA3213127A Division CA3213127A1 (en) 2015-04-15 2016-04-15 Derivatives of amphotericin b

Publications (2)

Publication Number Publication Date
CA3021061A1 CA3021061A1 (en) 2016-10-20
CA3021061C true CA3021061C (en) 2023-10-24

Family

ID=57126898

Family Applications (2)

Application Number Title Priority Date Filing Date
CA3021061A Active CA3021061C (en) 2015-04-15 2016-04-15 Derivatives of amphotericin b
CA3213127A Pending CA3213127A1 (en) 2015-04-15 2016-04-15 Derivatives of amphotericin b

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA3213127A Pending CA3213127A1 (en) 2015-04-15 2016-04-15 Derivatives of amphotericin b

Country Status (7)

Country Link
US (3) US9957290B2 (cg-RX-API-DMAC7.html)
EP (2) EP3929203A1 (cg-RX-API-DMAC7.html)
JP (3) JP7240811B2 (cg-RX-API-DMAC7.html)
CA (2) CA3021061C (cg-RX-API-DMAC7.html)
ES (1) ES2880029T3 (cg-RX-API-DMAC7.html)
PT (1) PT3283171T (cg-RX-API-DMAC7.html)
WO (1) WO2016168568A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201602570WA (en) 2013-10-07 2016-04-28 Univ Illinois Amphotericin b derivatives with improved therapeutic index
EP3156410A4 (en) 2014-06-12 2018-01-03 Shionogi & Co., Ltd. Polyene macrolide derivative
EP3929203A1 (en) * 2015-04-15 2021-12-29 Sfunga Therapeutics, Inc. Derivatives of amphotericin b
WO2017100171A1 (en) * 2015-12-08 2017-06-15 Kalyra Pharmaceuticals, Inc. Antifungal compounds and methods
WO2018106571A1 (en) * 2016-12-06 2018-06-14 Kalyra Pharmaceuticals, Inc. Antifungal compounds and methods
WO2020051465A1 (en) * 2018-09-07 2020-03-12 The Board Of Trustees Of The University Of Illinois Hybrid amphotericin b derivatives with reduced toxicity
WO2021026450A1 (en) * 2019-08-08 2021-02-11 The Board Of Trustees Of The University Of Illinois Hybrid amphotericin b derivatives with reduced toxicity
WO2021026520A1 (en) * 2019-08-08 2021-02-11 The Board Of Trustees Of The University Of Illinois Hybrid amide derivatives of amphotericin b
WO2022003181A1 (fr) * 2020-07-03 2022-01-06 Nanotracks Diagnostics Derivés urée de l'amphotéricine amb, compositions les contenant et leurs utilisations, dérivés isocyanate d'alkyle omega-aminés et leur utilisation pour obtenir lesdits dérivés urée
FR3112145A1 (fr) * 2020-07-03 2022-01-07 Nanotracks Diagnostics Derives uree de macrolides polyeniques, composes chimiques particuliers susceptibles d’etre utilises pour obtenir ces derives uree, compositions les contenant et utilisations
AU2021325676A1 (en) * 2020-08-10 2023-03-30 The Board Of Trustees Of The University Of Illinois Hybrid amide derivatives of amphotericin B

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8829592D0 (en) * 1988-12-19 1989-02-08 Beecham Group Plc Novel compounds
EP0350164A3 (en) * 1988-06-13 1991-07-24 Beecham Group Plc Amphotericin derivatives
EP0431870A1 (en) 1989-12-08 1991-06-12 Beecham Group p.l.c. Amphotericin B derivatives
CA2082951C (en) 1991-03-15 1999-12-21 Robert M. Platz Pulmonary administration of granulocyte colony stimulating factor
GB9203476D0 (en) * 1992-02-19 1992-04-08 Smithkline Beecham Plc Novel compounds
US5451569A (en) 1994-04-19 1995-09-19 Hong Kong University Of Science And Technology R & D Corporation Limited Pulmonary drug delivery system
US5606038A (en) * 1995-04-10 1997-02-25 Competitive Technologies, Inc. Amphiphilic polyene macrolide antibiotic compounds
PL180253B1 (pl) * 1995-05-13 2001-01-31 Politechnika Gdanska Pochodne N-metylo-N-glikozylowe estrów metylowych antybiotyków z grupy makrolidów polienowych i ich sole oraz sposób ich otrzymywania PL PL PL PL PL PL
US6664241B2 (en) * 2000-05-31 2003-12-16 Micrologix Biotech Inc. Water-soluble amide derivatives of polyene macrolides and preparation and uses thereof
EP1987049A1 (en) * 2006-02-23 2008-11-05 ETH Zürich Amphotericin derivatives
JP5240704B2 (ja) * 2007-10-05 2013-07-17 国立大学法人群馬大学 新規蛍光化合物およびそれを用いた細胞内コレステロールの検出方法
MX2014015249A (es) * 2012-06-15 2015-08-20 Blirt S A Derivados de segunda generacion del antibiotico antifungico anfotericina b de n-sustiduidos y metodos de su preparacion y aplicacion.
WO2014165676A1 (en) 2013-04-03 2014-10-09 The Board Of Trustees Of The University Of Illinois Amphotericin b derivative with reduced toxicity
SG11201602570WA (en) 2013-10-07 2016-04-28 Univ Illinois Amphotericin b derivatives with improved therapeutic index
WO2015164289A1 (en) * 2014-04-21 2015-10-29 Cidara Therapeutics, Inc. Compositions and methods for the treatment of fungal infections
EP3142672B1 (en) 2014-05-16 2019-09-25 The Board of Trustees of the University of Illionis Amphotericin b derivative with reduced toxicity
EP3156410A4 (en) * 2014-06-12 2018-01-03 Shionogi & Co., Ltd. Polyene macrolide derivative
WO2016014779A1 (en) 2014-07-23 2016-01-28 The Board Of Trustees Of The University Of Illinois Antifungal polyene macrolide derivatives with reduced mammalian toxicity
WO2016040779A1 (en) 2014-09-12 2016-03-17 The Board Of Trustees Of The University Of Illinois Urea derivatives of polyene macrolide antibiotics
AU2015331904B2 (en) 2014-10-17 2021-02-11 The Board Of Trustees Of The University Of Illinois Scalable synthesis of reduced toxicity derivative of amphotericin B
WO2016112260A1 (en) * 2015-01-08 2016-07-14 The Board Of Trustees Of The University Of Illinois Concise synthesis of urea derivatives of amphotericin b
WO2016112243A1 (en) 2015-01-08 2016-07-14 The Board Of Trustees Of The University Of Illinois Urea derivatives of amphotericin b derived from secondary amines
EP3929203A1 (en) * 2015-04-15 2021-12-29 Sfunga Therapeutics, Inc. Derivatives of amphotericin b

Also Published As

Publication number Publication date
PT3283171T (pt) 2021-07-14
JP7240811B2 (ja) 2023-03-16
EP3283171A4 (en) 2019-03-13
EP3283171B1 (en) 2021-05-26
EP3929203A1 (en) 2021-12-29
US20180273572A1 (en) 2018-09-27
EP3283171A1 (en) 2018-02-21
CA3213127A1 (en) 2016-10-20
US20160304548A1 (en) 2016-10-20
US10597420B2 (en) 2020-03-24
CA3021061A1 (en) 2016-10-20
JP2018514522A (ja) 2018-06-07
US10882883B2 (en) 2021-01-05
WO2016168568A1 (en) 2016-10-20
US20200262858A1 (en) 2020-08-20
ES2880029T3 (es) 2021-11-23
JP2023030103A (ja) 2023-03-07
HK1244248A1 (zh) 2018-08-03
JP2021075570A (ja) 2021-05-20
US9957290B2 (en) 2018-05-01

Similar Documents

Publication Publication Date Title
CA3021061C (en) Derivatives of amphotericin b
US10836750B1 (en) TLR7/8 antagonists and uses thereof
CA3110474C (en) Highly active sting protein agonist compound
AU2021201355B2 (en) Seco macrolide compounds
WO2024119277A1 (en) Kras inhibitors and pharmaceutical uses thereof
SK13972001A3 (sk) Erytromycínové deriváty
HK1244248B (en) Derivatives of amphotericin b
CA3024324C (en) Seco macrolide compounds
RU2630958C2 (ru) Новые макроциклические соединения, содержащие природное 3,7-диазабицикло[3.3.1]нонановое ядро и способ их получения
HK40048031A (en) Highly active sting protein agonist compound

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20210325

EEER Examination request

Effective date: 20210325

EEER Examination request

Effective date: 20210325

EEER Examination request

Effective date: 20210325

EEER Examination request

Effective date: 20210325

EEER Examination request

Effective date: 20210325

EEER Examination request

Effective date: 20210325

EEER Examination request

Effective date: 20210325

EEER Examination request

Effective date: 20210325